ARTICLE | Clinical News
Hemolink crosslinked hemoglobin 10 percent solution regulatory update
March 5, 2001 8:00 AM UTC
HML submitted an MAA for European approval of Hemolink to reduce use of donor red blood cells in coronary artery bypass graft (CABG) surgery. The product also is under review in Canada. ...